Association between anti-acid therapies and advanced fibrosis in type 2 diabetics with biopsy-proven non-alcoholic fatty liver disease.
Amandeep SinghRajat GargNan LanMohamed Tausif SiddiquiMohit GuptaNaim AlkhouriPublished in: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology (2020)
Our study suggests that H2RAs are associated with lower risk of AF in NAFLD patients with underlying diabetes and should be considered as the first-line antacid therapy in these patients. Risk stratification should be done if PPIs are indicated in high-risk diabetics with NAFLD.